Skip to main content
. 2019 May 15;156(4):685–695. doi: 10.1016/j.chest.2019.03.041

Table 2.

Total and Severe Exacerbation Frequency in Longitudinal Follow-Up

GOLD Stage/Exacerbation History Classic CB Definition
SGRQ CB Definition
Classic CB
Classic CB+
P Value SGRQ CB
SGRQ CB+
P Value
(n = 6,121) (n = 1,434) (n = 5,238) (n = 2,290)
All
 Exac freq (No./pt/y) 0.36 ± 0.90 0.69 ± 1.26 < .0001 0.31 ± 0.80 0.69 ± 1.29 < .0001
 Severe exac freq (No./pt/y) 0.13 ± 0.46 0.26 ± 0.74 < .0001 0.10 ± 0.39 0.26 ± 0.74 < .0001
 Exac freq ≥ 2/y (%) 4.7 10.5 < .0001 3.6 11.0 < .0001
 Severe exac freq ≥ 1/y (%) 3.6 7.4 < .0001 2.9 7.6 < .0001
GOLD stage 0 (n = 3,160) (n = 428) (n = 2,847) (n = 741)
 Exac freq (No./pt/y) 0.16 ± 0.63 0.30 ± 0.72 < .0001 0.15 ± 0.61 0.30 ± 0.78 < .0001
 Severe exac freq (No./pt/y) 0.06 ± 0.34 0.12 ± 0.45 < .0001 0.05 ± 0.30 0.12 ± 0.52 < .0001
 Exac freq ≥ 2/y (%) 1.6 3.2 .017 1.4 3.2 .002
 Severe exac freq ≥ 1/y (%) 1.6 3 .044 1.2 3.6 < .0001
GOLD stage 1-2 (n = 1,812) (n = 555) (n = 1,521) (n = 846)
 Exac freq (No./pt/y) 0.34 ± 0.74 0.64 ± 1.14 < .0001 0.31 ± 0.67 0.61 ± 1.09 < .0001
 Severe exac freq (No./pt/y) 0.11 ± 0.40 0.23 ± 0.68 < .0001 0.09 ± 0.31 0.22 ± 0.69 < .0001
 Exac freq ≥ 2/y (%) 4.1 9.4 < .0001 3.3 9.0 < .0001
 Severe exac freq ≥ 1/y (%) 2.7 6.1 < .0001 2.3 5.7 < .0001
GOLD stage 3-4 (n = 1,124) (n = 445) (n = 866) (n = 703)
 Exac freq (No./pt/y) 0.96 ± 1.39 1.12 ± 1.62 .040 0.84 ± 1.22 1.21 ± 1.70 < .0001
 Severe exac freq (No./pt/y) 0.35 ± 0.71 0.43 ± 0.96 .082 0.30 ± 0.64 0.46 ± 0.93 < .0001
 Exac freq ≥ 2/y (%) 14.7 19.1 .039 11.3 21.6 < .0001
 Severe exac freq ≥ 1/y (%) 10.9 13.3 .189 9.5 14.1 .005

Data are expressed as mean ± SD or percent. Probability values in boldface indicate significance. GOLD = Global Initiative for Chronic Obstructive Lung Disease; pt = patient. See Table 1 legend for expansion of other abbreviations.